title: Effect of aerobic training on EEG alpha asymmetry and depressive symptoms in the elderly: a 1-year follow-up study.
abstract: The effect of physical exercise on the treatment of depressive elderly adults has not been investigated thus far in terms of changes in cortical hemispheric activity. The objective of the present study was to identify changes in depressive symptoms, quality of life, and cortical asymmetry produced by aerobic activity. Elderly subjects with a diagnosis of major depressive disorder (DSM-IV) were included. Twenty patients (70% females, 71 +/- 3 years) were divided into an exercise group (pharmacological treatment plus aerobic training) and a control group (undergoing pharmacological treatment) in a quasi-experimental design. Pharmacological treatment was maintained stable throughout the study (antidepressants and anxiolytics). Subjects were evaluated by depression scales (Beck Depression Inventory, Hamilton Depression Rating Scale, Montgomery-Asberg Depression Rating Scale) and the Short Form Health Survey-36, and electroencephalographic measurements (frontal and parietal alpha asymmetry) before and after 1 year of treatment. After 1 year, the control group showed a decrease in cortical activity on the right hemisphere (increase of alpha power), which was not observed in the exercise group. The exercise group showed a significant decrease of depressive symptoms, which was not observed in the control group. This result was also accompanied by improved treatment response and remission rate after 1 year of aerobic exercise associated with treatment. This study provides support for the effect of aerobic training on alpha activity and on depressive symptoms in elderly patients. Exercise facilitates the treatment of depressive elderly adults, leading to clinical and physical improvement and protecting against a decrease in cortical activity.
authors.affiliation: Centro de Doença de Alzheimer e Outros Transtornos da Velhice, Universidade Federal do Rio de Janeiro, Brazil. adeslandes@ufrj.br <adeslandes@ufrj.br>
authors.forename: A C
authors.initials: AC
authors.lastname: Deslandes
authors.forename: H
authors.initials: H
authors.lastname: Moraes
authors.forename: H
authors.initials: H
authors.lastname: Alves
authors.forename: F A M S
authors.initials: FA
authors.lastname: Pompeu
authors.forename: H
authors.initials: H
authors.lastname: Silveira
authors.forename: R
authors.initials: R
authors.lastname: Mouta
authors.forename: C
authors.initials: C
authors.lastname: Arcoverde
authors.forename: P
authors.initials: P
authors.lastname: Ribeiro
authors.forename: M
authors.initials: M
authors.lastname: Cagy
authors.forename: R A M
authors.initials: RA
authors.lastname: Piedade
authors.forename: J
authors.initials: J
authors.lastname: Laks
authors.forename: E S F
authors.initials: ES
authors.lastname: Coutinho
mesh_terms: D000368:Aged; D000513:Alpha Rhythm; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003865:Major Depressive Disorder / Q000523:psychology / Q000628:therapy*; D004569:Electroencephalography; D005081:Exercise Therapy / Q000379:methods*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales; D011788:Quality of Life
chemical_list: D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents